Neuropharmacological therapy of carcinoid syndrome

Neuroendocrinology

Volumn 81, Issue 3, 2005, Pages 137-138

  Lechin, Fuad ^a,b   Van Der Dijs, Bertha ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b NONE   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMINO ACID DERIVATIVE; DOPAMINE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; NORADRENALIN; NORADRENALINE UPTAKE ENHANCER; PROLACTIN; PSYCHOTROPIC AGENT; SEROTONIN; TRYPTOPHAN; UNCLASSIFIED DRUG; YOHIMBINE;

ADRENAL GLAND; ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CANCER REGRESSION; CARCINOID SYNDROME; CELL STRAIN K 562; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTEROCHROMAFFIN CELL; GASTROINTESTINAL MOTILITY; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; LETTER; NEUROPHARMACOLOGY; NORADRENERGIC SYSTEM; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYMPTOM; TH2 CELL;

ADRENAL GLANDS; ADRENERGIC AGENTS; CENTRAL NERVOUS SYSTEM; FOLLOW-UP STUDIES; HUMANS; MALIGNANT CARCINOID SYNDROME; NOREPINEPHRINE; SEROTONIN; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 23844449709     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086526     Document Type: Letter

References (12)

1. Ruszniewski P, Ish-Shalom S, Wymenga M, O'Toole D, Arnold R, Tomassetti P, Bax N, Caplin M, Eriksson B, Glaser B, Ducreux M, Lombard-Bohas C, de Herder WW, Fave GD, Reed N, Seitz JF, Van Cutsem E, Grossman A, Rougier P, Schmidt W, Wiedenmann B: Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged release formulation of lanreotide. Neuroendocrinology 2004;80:244-251.
2. Lechin F, van der Dijs B, Orozco B, Hernandez-Adrian G, Rodríguez S, Baez S: Neuropharmacological therapy of the neuroendocrine carcinoid syndrome: report of two cases. J Appl Res 2005;5:109-114.
3. Lechin F, van der Dijs B, Orozco B, Lechin AE, Baez S, Lechin ME, Benaim M, Acosta E, Arocha L, Jimenez V, Leon G, Garcia Z: Plasma neurotransmitters, blood pressure and heart rate during supine resting, orthostasis and moderate exercise in severelly ill patients: A model of failing to cope with stress. Psychother Psychosom 1996;65:129-136.
4. Lechin F, van der Dijs B, Lechin AE, Lechin M, Coll-Garcia E, Jara H, Cabrera A, Jimenez V, Gomez F, Tovar D, Rada I, Arocha L: Doxepin therapy for postprandial symptomatic hypoglycaemic patients: neurochemical, hormonal and metabolic disturbances. Clin Sci 1991;80:373-384.
5. Lechin F, van der Dijs B, Jakubowicz D, Camero RE, Villa S, Lechin E, Gomez F: Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone subjects. Neuroendocrinology 1985;40:253-261.
6. Lechin F, van der Dijs B, Lechin ME: Illustrations of some therapeutic results; in Lechin F, van der Dijs B, Lechin ME (eds): Neurocircuitry and Neuroautonomic Disorders. Reviews and Therapeutic Strategies. Basel, Karger, 2002, pp 75-81.
7. Tobe T, Izumikawa F, Sano M, Tnaka C: Release mechanisms of 5-HT in mammalian gastrointestinal tract - especially vagal release of 5-HT; in Fujita T (ed): Endocrine Gut-Pancreas. Amsterdam, Elsevier, 1976, pp 371-380.
8. 3 receptor binding sites in human dorsal vagal complex. Eur J Pharmacol 1989;174:127-130.
9. Rausch JL, Janowsky DS, Risch SC, Huey LY: Physostigmine effects on serotonin uptake in human blood platelets. Eur J Pharmacol 1985;109:91-96.
10. Haft JI, Arkel YS: Effect of emotional stress on platelet aggregation in humans. Chest 1976;70:501-506.
11. Lechin F, van der Dijs B, Vitelli G, Lechin-Baez S, Azócar J, Cabrera A, Lechin A, Jara H, Lechin M, Gómez F, Arocha L: Psychoneuroendocrinological and immunological parameters in cancer patients: Involvement of stress and depression. Psychoneuroendocrinology 1990;15:435-451.
12. Lechin F, van der Dijs B, Lechin AE: Natural killer cells activity and neuroimmunological treatment of cancer. Clin Cancer Res 2004;10:8120-8121.